Donald E. Bobo Jr. - 27 May 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: CVP,Strategy/Corp Development
Issuer ticker: EW
Reported as of: 27 May 2026
Net transaction value: -$2,000,193
SEC form: 4
Accepted by SEC: 27 May 2026, 19:28:36 UTC
Prior SEC filing: 18 May 2026
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Donald E. Bobo Jr. filed Form 4 for Edwards Lifesciences Corp (EW) on 27 May 2026.

Key facts

This page summarizes Donald E. Bobo Jr.'s Form 4 filing for Edwards Lifesciences Corp (EW).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 May 2026, 19:28.

Change

Previous filing in this sequence was filed on 18 May 2026.
Current net transaction value: -$2,000,193.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001196661 Primary reporting owner

BOBO DONALD E JR

Relationship: CVP,Strategy/Corp Development
Address: ONE EDWARDS WAY, IRVINE
Signature: Linda J. Park, Attorney-in-Fact
Signature date: 27 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Sale

Transaction value: $2,000,193
Shares: -23,145
Change %: -19%
Price: $86.42
Shares after: 98,611
Date: 27 May 2026
Ownership: By Trust
Footnotes: F1

EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 22,798
Date: 27 May 2026
Ownership: Direct

EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 30,970
Date: 27 May 2026
Ownership: 401(k)

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple trades at prices ranging from $86.27 to $86.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.